Last reviewed · How we verify

transforaminal epidural injection.

Beni-Suef University · FDA-approved active Small molecule Under review

transforaminal epidural injection. is a Small molecule drug developed by Beni-Suef University. It is currently FDA-approved for Radiculopathy due to disc herniation or spinal stenosis, Nerve root compression pain, Sciatica.

Transforaminal epidural injection delivers corticosteroids and/or local anesthetics directly into the epidural space via the intervertebral foramen to reduce inflammation and pain in nerve root compression.

A transforaminal epidural injection is a medical procedure used to treat conditions such as neuropathic pain from lumbosacral radiculopathy, chronic pain, and lumbar radiculopathy. The procedure typically involves injecting a solution, such as a compound solution of sodium chloride, into the epidural space through a foramen in the spine.

At a glance

Generic nametransforaminal epidural injection.
SponsorBeni-Suef University
ModalitySmall molecule
Therapeutic areaPain Management / Neurology
PhaseFDA-approved

Mechanism of action

This is a minimally invasive interventional procedure rather than a systemically administered drug. The injection targets the epidural space surrounding the spinal cord and nerve roots, delivering anti-inflammatory corticosteroids (commonly methylprednisolone or triamcinolone) and local anesthetics (typically lidocaine) to reduce inflammation, edema, and pain associated with nerve root irritation. The transforaminal approach allows direct access to the affected nerve root via the neural foramen.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about transforaminal epidural injection.

What is transforaminal epidural injection.?

transforaminal epidural injection. is a Small molecule drug developed by Beni-Suef University, indicated for Radiculopathy due to disc herniation or spinal stenosis, Nerve root compression pain, Sciatica.

How does transforaminal epidural injection. work?

Transforaminal epidural injection delivers corticosteroids and/or local anesthetics directly into the epidural space via the intervertebral foramen to reduce inflammation and pain in nerve root compression.

What is transforaminal epidural injection. used for?

transforaminal epidural injection. is indicated for Radiculopathy due to disc herniation or spinal stenosis, Nerve root compression pain, Sciatica.

Who makes transforaminal epidural injection.?

transforaminal epidural injection. is developed and marketed by Beni-Suef University (see full Beni-Suef University pipeline at /company/beni-suef-university).

What development phase is transforaminal epidural injection. in?

transforaminal epidural injection. is FDA-approved (marketed).

What are the side effects of transforaminal epidural injection.?

Common side effects of transforaminal epidural injection. include Transient increase in pain, Headache, Dizziness, Infection at injection site, Bleeding/hematoma, Nerve injury.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing